Drug
Elecoglipron
Elecoglipron: highest development phase Phase 3, developed by AstraZeneca. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Elecoglipron NCT07775404 | Phase 3 | Obesity |
| Elecoglipron NCT07534592 | Phase 1 |
Latest
No recent events.
Follow Elecoglipron on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.